Brief: Standard BioTools Q1 EPS USD 0.33
05/05/2026 21:05
May 05 (Reuters) - Standard BioTools Q1 gross margin 53.5%. Q1 net income USD 127.068 million Q1 revenue USD 21.1 million Q1 pretax profit USD -14.615 million Q1 operating income USD -12.5 million Q1 adjusted gross margin 57.7% Q1 adjusted EBITDA USD -3.1 million
Recent news on Standard BioTools
See all newsBrief: Standard Biotools Announces Agreement To Sell Microfluidics Business To Archimed
Brief: Standard Biotools Provides Update On Sale Of Mass Cytometry Business
Standard BioTools Inc. reports results for the quarter ended June 30 - Earnings Summary
Standard BioTools Q2 revenue falls on consumables weakness
Brief: Standard BioTools Q2 EPS USD -0.07